Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.26 is 60% above its 5-year average of -0.66, around the middle of its 5-year range (-3.00–1.71).
As of the fiscal period ended Wednesday, December 31, 2025. 85.27% above its 12-month average of -1.77.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 29 quarters.
EARNINGS PER SHARE (EPS)
-0.26
EARNINGS PER SHARE (EPS) AVG TTM
-1.77
EARNINGS PER SHARE (EPS) AVG 3Y
-0.44
EARNINGS PER SHARE (EPS) AVG 5Y
-0.66
EARNINGS PER SHARE (EPS) AVG 10Y
-0.10
EARNINGS PER SHARE (EPS) AVG 15Y
0.76
EARNINGS PER SHARE (EPS) AVG 20Y
0.47
CURRENT VS TTM AVG
+85.27%
CURRENT VS 3Y AVG
+41.39%
CURRENT VS 5Y AVG
+60.35%
CURRENT VS 10Y AVG
-167.54%
CURRENT VS 15Y AVG
-134.13%
CURRENT VS 20Y AVG
-155.52%
Viatris Inc.
Market Cap
$20.55B
Earnings Per Share (EPS)
-0.26
TTM Avg
-1.77
3Y Avg
-0.44
5Y Avg
-0.66
Market Cap
$22.03B
Earnings Per Share (EPS)
27.05
TTM Avg
28.29
3Y Avg
23.40
5Y Avg
19.31
Market Cap
$18.99B
Earnings Per Share (EPS)
3.85
TTM Avg
4.00
3Y Avg
3.51
5Y Avg
2.55
Market Cap
$22.32B
Earnings Per Share (EPS)
-7.98
TTM Avg
-8.27
3Y Avg
-1.90
5Y Avg
3.46
Market Cap
$23.16B
Earnings Per Share (EPS)
-5.94
TTM Avg
-4.08
3Y Avg
9.21
5Y Avg
14.48
Market Cap
$16.97B
Earnings Per Share (EPS)
2.40
TTM Avg
2.92
3Y Avg
3.22
5Y Avg
4.07
Market Cap
$24.28B
Earnings Per Share (EPS)
7.85
TTM Avg
3.38
3Y Avg
2.74
5Y Avg
2.31
Market Cap
$16.41B
Earnings Per Share (EPS)
17.07
TTM Avg
14.35
3Y Avg
11.37
5Y Avg
9.10
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viatris Inc. (VTRS) | $20.55B | -0.26 | -1.77 | -0.44 | -0.66 |
| United Therapeutics Corporation (UTHR)vs › | $22.03B | 27.05 | 28.29 | 23.40 | 19.31 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.99B | 3.85 | 4.00 | 3.51 | 2.55 |
| Moderna, Inc. (MRNA)vs › | $22.32B | -7.98 | -8.27 | -1.90 | 3.46 |
| STERIS plc (STE)vs › | $22.68B | 7.93 | 7.08 | 4.77 | 4.37 |
| BioNTech SE (BNTX)vs › | $23.16B | -5.94 | -4.08 | 9.21 | 14.48 |
| Hologic, Inc. (HOLX)vs › | $16.97B | 2.40 | 2.92 | 3.22 | 4.07 |
| Incyte Corporation (INCY)vs › | $24.28B | 7.85 | 3.38 | 2.74 | 2.31 |
| Medpace Holdings, Inc. (MEDP)vs › | $16.41B | 17.07 | 14.35 | 11.37 | 9.10 |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.72B | 7.82 | 6.79 | 7.36 | 7.17 |
Trailing EPS (TTM)
$-0.26
Forward EPS (Est.)
$2.45
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.00 |
| 2024-12-31 | -0.53 |
| 2023-12-31 | 0.05 |
| 2022-12-31 | 1.71 |
| 2021-12-31 | -1.05 |
| 2020-12-31 | -1.11 |
| 2019-12-31 | 0.03 |
| 2018-12-30 | 0.69 |
| 2017-12-30 | 1.30 |
| 2016-12-30 | 0.94 |
| 2015-12-30 | 1.80 |
| 2014-12-30 | 2.49 |
| 2013-12-30 | 1.63 |
| 2012-12-31 | 1.54 |
| 2011-12-31 | 1.25 |
| 2010-12-31 | 0.69 |
| 2009-12-31 | 0.31 |
| 2008-12-31 | -0.64 |
| 2007-12-31 | -5.90 |
| 2006-03-31 | 0.80 |
| 2005-03-31 | 0.76 |
| 2004-03-31 | 1.24 |
Reported annual fiscal-period values; no daily interpolation.
